Pembrooke Occupational Health, Inc.

Pembrooke Occupational Health, Inc., operating as Abbott Escreen Division and doing business as Pembrooke, delivers drug and alcohol testing, specimen collection, laboratory analysis, and medical review officer services to federal agencies as a prime contractor competing full and open without set-asides. A subsidiary of Abbott Laboratories headquartered in Richmond, Virginia, Pembrooke operates under primary NAICS 621511 (Medical Laboratories) and PSC Reference Laboratory Testing, with 231 prime awards totaling $200 million in combined potential value across forty distinct customer agencies since 2004.

Customer concentration clusters heavily at the Department of the Interior's Interior Business Center, which accounts for 23 awards and $56.4 million in combined potential value—28% of Pembrooke's total federal portfolio. The Department of Justice components (Bureau of Prisons, U.S. Marshals Service, and the Bureau of Alcohol, Tobacco, Firearms and Explosives) represent the volume leader by award count: 52 awards totaling $2.8 million combined potential value across thirty Bureau of Prisons orders, eleven Marshals Service orders, and eleven ATF orders. The Department of Homeland Security (Secret Service), Department of Labor, and Department of Energy complete the active customer set. The two rankings diverge markedly—the Interior Business Center dominates dollars through a single high-value vehicle, while the Bureau of Prisons and Marshals Service anchor volume through numerous smaller task orders.

Pembrooke's vehicle footprint is anchored by a $22.7 million single-award indefinite delivery contract with the Department of Interior's Interior Business Center (IDC 140D0423D0045), awarded March 1, 2023, through February 29, 2028, which has generated 22 task orders totaling $9.1 million to date. Three additional IDCs carry significant task-order volume: IDC INDNBCD05002 with 49 task orders valued at $11.7 million, IDC IND12PC00529 with 33 task orders valued at $7.7 million, and IDC 140D7018D0002 with 28 task orders valued at $7.9 million. Representative prime work includes a $46.4 million firm fixed-price definitive contract awarded by the Office of the Secretary of Defense on May 15, 2025, for civilian drug-free workplace collections and medical review officer support services through February 19, 2030; a $1.16 million delivery order from the Interior Business Center (April 1, 2026, through March 31, 2027) for comprehensive testing services; and a $1.8 million Interior Business Center delivery order (April 1, 2025, through March 31, 2026) for specimen collection and tracking.

Activity has contracted in recent years—nine awards in 2023, five in 2024, and six in 2025—with only four awards recorded in 2026 year-to-date. Seven awards totaling $3.1 million in combined potential value face ultimate completion within the next twenty-four months and carry recompete risk. Service Contract Inventory reporting captures $5.7 million in SCI-reportable invoiced prime revenue across FY2022–FY2024 (FY2022: $1.5 million across 4.6 FTEs; FY2023: $2 million across 12.0 FTEs; FY2024: $2.2 million across 12.0 FTEs), representing a subset of Pembrooke's total federal services activity and a smaller portion of Abbott Laboratories' enterprise revenue. On SCI-reportable federal service contracts, median government-paid rates run $118.03 per hour, with senior labor pricing through $156.24 per hour and entry-level rates around $7.36 per hour. Pembrooke self-performs across SCI records with zero subcontractor hours, maintaining integrated delivery of specimen collection, laboratory analysis, and medical review functions across a distributed footprint.